Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-29

Clinical Trial Update: Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers [NA]

View source ↗

Summary

A clinical trial comparing diosmin-hesperidin to loratadine for preventing G-CSF–induced bone pain in patients with hematologic malignancies and neutropenia; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diosmin-Hesperidin
  • Loratadine (Loratadine)

Snippet

Sponsor: Alexandria University | Conditions: Hematologic Malignancy, Neutropenia | NA | Status: RECRUITING